Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »

Australia: THC completes Queensland R&D and cultivation facility

The Hydroponics Company has successfully completed stage 1 of its R&D facility and growing capability in Queensland. Since October 2017, THC has increased the investment in, and focus upon, the development of the Queensland site.

The site has been developed to allow for increasing demand for high quality medicinal cannabis products in both local and export markets. Stage 1 of the development includes greenhouses for indoor cultivation and growth of medicinal cannabis, a drying and shredding facility for the initial processing of the dried plants, and an extraction laboratory for the processing of crude extract from the shredded plants.

The site will also provide an onsite laboratory for development of new strains, as well as testing and quality control of harvested products. The current site, when fully optimized, will be scalable to meet the demands of a growing market.

THC plans to vertically integrate along the industry value chain by producing a high quality, processed product that will differentiate THC from companies focused solely upon the production of medicinal cannabis as an agricultural commodity. Stage 2 of the Strategic Growth plan for THC is to further process the raw material (dry bud) into higher value medicinal cannabis oils for use in both Australian and international patients. These products will be provided to approved Australian patients through the National Access Cannabis clinics in Australia as a branded product, along with other premium products from international partners. Conversations have commenced with National Access Cannabis, Canada to supply high quality Canndeo products to supplement NAC’s existing product portfolio. As at 31 August 2017, NAC Canada had in excess of 8,500 members.

David Radford of THC states: "The Board recognises the significant contribution of the Queensland team to the growth of the business. This small team has contributed significantly to the development and submission of the licence applications to the ODC, whilst managing the build out. We look forward to being granted the manufacturing licence and final approvals in order to commence the growing and manufacturing program of high quality medicinal products”.

For more information:
The Hydroponics Company
Suite 305, Level 3, 35 Lime Street
Sydney, NSW 2000 Australia

Publication date: 2/21/2018



Other news in this sector:

3/16/2018 US: Indoor Harvest forms scientific advisory board
3/15/2018 CAN (ON): Job growth skyrockets as MJ industry ramps up
3/14/2018 CAN (ON): Aphria adds 200,000 sq.ft. to triple production
3/13/2018 CAN (NL): Canopy Growth secures cannabis site
3/12/2018 Jamaica's first legal MMJ facility opens
3/12/2018 US (CA): Calaveras County MMJ growers face ban
3/9/2018 US (CA): MMJ sales are escalating, along with growers' energy costs
3/9/2018 Meet Canada's marijuana moguls
3/8/2018 "America is giving away the $30 billion medical marijuana industry"
3/8/2018 Prepping the largest cannabis grow in Canada
3/8/2018 US (WA): 28,000 sq.ft. MMJ facility nears completion
3/7/2018 UN report reveals UK is world’s biggest producer of medical cannabis
3/7/2018 "There really is no such thing as medical marijuana"
3/6/2018 CAN (BC): Village Farms starts 1.1 million sq.ft. cannabis cultivation
3/5/2018 CAN (BC): 26,000 sq.ft. MMJ greenhouse planned on Gabriola Island
3/2/2018 US (ME): 35,000 sq.ft. MMJ farm for sale
3/2/2018 Australia: MMJ grower educates doctors
3/2/2018 US (FL): MMJ grower expects to make $3 million from 10-acre greenhouse
3/1/2018 US (NV): Marapharm finalizes installations in Las Vegas
2/28/2018 Lesotho-based MMJ grower to export to Canada